REFERENCES
The complete list of references can be found at www.expertconsult.com.
REFERENCES
Antimicrobial Stewardship
1. Dellit TH, Owens RC, McGowand JE, et al: Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clm Infect Dis 44:159, 2007.
2. Pile JC: Antimicrobial stewardship: optimizing antibiotic use in an era of increasing resistance and rising costs, J Hosp Med 6:S1, 2011.
3. Antimicrobial stewardship definition and core principles. Available at: www. avma.org/KB/Policies/Pages/Antimicrobial-Stewardship-Definition-and- Core-Principles.aspx. (Accessed 25 July 2018).
4. Antimicrobial stewardship in companion animal practice. Available at: www. avma.org/KB/Resources/Reports/Pages/Antimicrobial-Stewardship-in- Companion-Animal-Practice.aspx. (Accessed 25 July 2018).
5. Guardabassi L, Prescott JF: Antimicrobial stewardship in small animal veterinary practice: from theory to practice, Vet Clin Small Anim 45:361, 2015.
6. Lloyd DH, Page SW: Antimicrobial stewardship in veterinary medicine, Microbiol Spectr 6:2018. ARBA-0023-2017.
7. Hardefeldt LY: Implementing antimicrobial stewardship programmes in veterinary practices, Vet Rec 182:688, 2018.
8. Page SW, Prescott JF: The 5rs approach to antimicrobial stewardship, Vet Rec 175:207, 2014.
9. Judicious therapeutic use of antimicrobials. Available at: www.avma.org/ KB/Policies/Pages/Judicious-Therapeutic-Use-of-Antimicrobials.aspx. (Accessed 25 July 2018).
10. AABP/AVMA Judicious therapeutic use of Antimicrobials in cattle. Available at: www.avma.org/KB/Policies/Pages/AABP-Prudent-Drug-Usage -Guidelines-for-Cattle.aspx. (Accessed 25 July 2018).
11. American Association of Equine Practitioners - AVMA Prudent drug use guidelines. Available at: www.avma.org/KB/Policies/Pages/AAEP-Prudent- Drug-Usage-Guidelines.aspx.
(Accessed 25 July 2018).12. American Association of Swine Veterinarians basic guidelines of judicious therapeutic use of antimicrobials in pork production. Available at: www. avma.org/KB/Policies/Pages/AASV-Basic-Guidelines-of-Judicious- Therapeutic-Use-of-Antimicrobials-in-Pork-Production.aspx. (Accessed 26 July 2018).
13. Morley PS, Apley MD, Besser TE, et al: Antimicrobial drug use in veterinary medicine, J Vet Intern Med 19:617, 2005.
14. Weese JS, Giguere S, Guardabassi L, et al: ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance, J Vet Intern Med 29:487, 2015.
15. Weese JS, Page SW, Prescott JF: Antimicrobial stewardship in animals. In Giguere S, Prescott JF, Dowling PM, editors: Antimicrobial therapy in veterinary medicine, ed 5, Ames, IA, 2013, John Wiley and Sons Inc., pp 117-132.
16. Cray C, Zaias J, Altman NH: Acute phase response in animals: a review, Comp Med 59:517, 2009.
17. Lorenzo-Figueras M, Pusterla N, Byrne BA, et al: In vitro evaluation of three bacterial culture systems for the recovery of Escherichia coli from equine blood, Am J Vet Res 67:2025, 2006.
18. CLSI: Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals, ed 3, CLSI supplement VET01S, Wayne, PA, 2015, Clinical and Laboratory Standards Institute, Wayne, PA.
19. Turnidge J, Paterson DL: Setting and revising antibacterial susceptibility breakpoints, Clin Microbiol Rev 20:391, 2007.
20. Owens RC, Bulik CC, Andes DR: Pharmacokinetics-phrmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder, Diagn Microbiol Infect Dis 91:371, 2018.
21. Mouton JW, Dudley MN, Cars O, et al: Standardization of pharmacokinetic/ pharmacodynamics (PK/PD) terminology for anti-infective drugs, Int J Antimicrob Agents 19:355, 2002.
22. Boothe DM: Principles of antimicrobial therapy, Vet Clin North Am Small Anim Pract 36:1003, 2006.
23. McKinnon PS, Davis SL: Pharmacokinetic and pharmacodynamics issues in the treatment of bacterial infectious diseases, Eur J Clin Microbiol Infect Dis 23:271, 2004.
24. Schentag JJ, Meagher AK, Forrest A: Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: in vitro and animal models, Ann Pharmacother 37:1287, 2003.
25. Schentag JJ, Meagher AK, Forrest A: Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials, Ann Pharmacother 37:1478, 2003.
26. Martinez M, Toutain PL, Walker RD: The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents. In Giguere S, Prescott JF, Baggot JD, et al, editors: Antimicrobial therapy in veterinary medicine, ed 4, Ames, IA, 2006, Blackwell Publishing, pp 81-106.
27. Martinez M, Toutain PL, Turnidge J: The pharmacodynamics of antimicrobial agents. In Giguere S, Prescott JF, Dowling PM, editors: Antimicrobial therapy in veterinary medicine, ed 5, Ames, IA, 2013, John Wiley and Sons Inc., pp 79-103.
28. Eliopoulos GM, Moellering RC: Principles of anti-infective therapy. In Bennett JE, Dolin R, Blaser MJ, editors: Mandell, Douglas, and Bennett' principles and practice of infectious diseases, ed 8, Philadelphia, PA, 2015, Elsevier, pp 224-234.
29. Lepper MH, Dowling HF: Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin, AMA Arch Intern Med 88:489, 1951.
30. Sande MA, Overton JW: In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice, J Infect Dis 128:247, 1973.
31. Ensink JM, Klein WR, Mevius DJ, et al: Bioavailability of oral penicillins in the horse: a comparison of pivampicillin and amoxicillin, J Vet Pharmacol Ther 15:221, 1992.
32. Baggot JD, Short CR: Drug disposition in the neonatal animal, with particular reference to the foal, Equine Vet J 16:364, 1984.
33. Yabe K, Satoh H, Ishii Y, et al: Early pathophysiologic feature of arthropathy in juvenile dogs induced by ofloxacin, a quinolone antimicrobial agent, Vet Pathol 41:673, 2004.
34. Pfister K, Mazur D, Vormann J, et al: Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats, Antimicrob Agents Chemother 51:1022, 2007.
35. Khaliq Y, Zhanel GG: Fluoroquinolone-associated tendinopathy: a critical review of the literature, Clin Infect Dis 36:1404, 2003.
36. Egerbacher M, Edinger J, Tschulenk W: Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture, Am J Vet Res 62:704, 2001.
37. Lim S, Hossain MA, Park J, et al: The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro, Vet Res Commun 32:243, 2008.
38. Sansone JM, Wilsman NJ, Leiferman EM, et al: The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model, J Pediatr Orthop 29:189, 2009.
39. Fenger CK, Granstrom DE, Langemeier JL, et al: Epizootic of equine protozoal myeloencephalitis on a farm, J Am Vet Med Assoc 210:923, 1997.
40. Bedford SJ, McDonnell SM: Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine, J Am Vet Med Assoc 215:1317, 1999.
41. Garnacho-Monter J, Arenzana-Seisdedos A, De Waele J, et al: To which extent can we decrease antibiotic duration in critically ill patients?, Expert Rev Clin Pharmacol 10:1215, 2017.
42. Classen DC, Evans RS, Pestotnik SL, et al: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection, N Engl J Med 326:281, 1992.
43. Moore RM, Schneider RK, Kowalski J, et al: Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989, Equine Vet J 24:450, 1992.
44. Schneider RK, Bramlage LR, Moore RM, et al: A retrospective study of 192 horses affected with septic arthritis/tenosynovitis, Equine Vet J 24:436, 1992.
45. Harvey A, Kilcoyne I, Byrne BA, et al: Effect of dose on intra-articular amikacin sulfate concentrations following intravenous regional limb perfusion in horses, Vet Surg 45:1077, 2016.
46. Barie PS, Eachempati SR: Surgical site infections, Surg Clin North Am 85:1115, 2005.
47. Steinberg JP, Braun BI, Hellinger WC, et al: Timing of antimicrobial prophylaxis and the risk of surgical site infections, Ann Surg 250:10, 2009.
48. Boothe DM, Boothe HW: Antimicrobial considerations in the perioperative patient, Vet Clin North Am Small Anim Pract 45:585, 2015.
49. Bratzler DW, Houck PM: Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project, Clin Infect Dis 38:1706, 2004.
50. Southwood LL: Principles of antimicrobial therapy: what should we be using?, Vet Clin North Am Equine Pract 22:279, 2006.
51. Johnson JC, Bryson WL, Barringer S, et al: Evaluation of on-arrival versus prompted metaphylaxis regimes using ceftiofur crystalline free acid for feedlot heifers at risk of developing bovine respiratory disease, Vet Ther 9:53, 2008.
52. Taylor JD, Fulton RW, Lehenbauer TW, et al: The epidemiology of bovine respiratory disease: what is the evidence for preventive measures?, Can Vet J 51:1351, 2010.
53. Baptiste KE, Kyvsgaard NC: Do antimicrobial mass medications work? A systematic review and meta-analysis of randomized clinical trials investigating antimicrobial prophylaxis or metaphylaxis against naturally occurring bovine respiratory disease, Pathog Dis 75:1, 2017.
54. Teixeira AGV, McArt JAA, Bicalo RC: Efficacy of tildiprosin metaphylaxis for the prevention of respiratory disease, otitis and mortality in pre-weaned holstein calves, Vet J 219:44, 2017.
55. Snyder E, Credille B, Berghause R, et al: Prevalence of multidrug antimicrobial resistance in Mannheimia haemolytica isolated from high-risk stocker cattle at arrival and two weeks after processing, J An Sci 95:1124, 2017.
56.
Dunowska M, Morley PS, Traub-Dargatz JL: Impact of hospitalization and antimicrobial drug administration on antimicrobial susceptibility patterns of commensal Escherichia coli isolated from the feces of animals, J Am Vet Med Assoc 228:1909, 2006.57. Maddox TW, Williams NJ, Clegg PD, et al: Longitudinal study of antimicrobial-resistant commensal Escherichia coli in the faeces of horses in an equine hospital, Prev Vet Med 100:134, 2011.
58. Ahmed MO, Williams NJ, Clegg PD, et al: Analysis of risk factors associated with antibiotic-resistant Escherichia coli, Microb Drug Resist 18:161, 2012.
59. Callens B, Faes C, Maes D, et al: Presence of antimicrobial resistance and antimicrobial use in sows are risk factors for antimicrobial resistance in their offspring, Microb Drug Resist 21:50, 2015.
60. Hall-Stoodley L, Stoodley P, Kathju S, et al: Toward diagnostic guidelines for biofilm-associated infections, FEMS Immunol Med Microbiol 65:127, 2012.
61. Muntener C, Bruckner L, Kupper J, et al: Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2011, Schweiz Arch Tierheilkd 154:513, 2012.
Medication Use in Food-Producing Animals
1. U.S. Food and Drug Administration: Animal & Veterinary. 2009. Appendix III, Species and Classes of Major Food Animals. In CVM’s Guidance for Industry (GFI) #191: Changes to Approved NADAs-New NADAs vs. Category II Supplemental NADAs. [WWW page]. https://www.fda.gov/ downloads/AnimalVeterinary/GuidanceComplianceEnforcement/Guid- anceforIndustry∕UCM052460.pdf. (Accessed 20 July 2018).
2. U.S. Government Printing Office. 2013. Electronic Code of Federal Regulations, Title 9, Part 51.1. [WWW page]. https://www.ecfr.gov/cgi-bin/ text-idx?SID=cb0eaa6df4fb91e8d278ad26f8abbbf9&mc=true&node=se9. 1.51_11&rgn=div8. (Accessed 20 July 2018).
3. U.S. Food and Drug Administration (FDA). 2012. Code of Federal Regulations, Title 21, Part 530. Extra label drug use in animals. [WWW page]. https://www.ecfr.gov/cgi-bin/text-idx?SID=35f21e6978e6b757264376a37 ebfe20e&mc=true&node=pt21.6.530&rgn=div5. (Accessed 20 July 2018).
4. Riviere JE, Sundlof SF: Chemical residues in tissues of food animals. In Riviere JE, Papich MG, editors: Veterinary pharmacology & therapeutics, ed 9, Oxford, 2009, Blackwell Publishing.
5. U.S. Food and Drug Administration (FDA). 2001. Extralabel use of medicated feeds for minor species (CPG615.115). http://www.fda.gov/ ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ ucm074659.htm. (Accessed 20 July 2018).
6. Davis JL, Smith GW, Baynes RE, et al: Update on drugs prohibited from extralabel use in food animals, J Am Vet Med Assoc 235:528, 2009.
7. Food Animal Residue Avoidance and Depletion. 2013. Restricted and Prohibited Drugs in Food Animals. [WWW page]. http://www.farad.org/ prohibited-and-restricted-drugs.html. (Accessed 20 July 2018).
8. American Veterinary Medical Association. 2013. Animal Medicinal Drug Use Act (AMDUCA). [WWW page]. https://www.avma.org/KB/Resources/ Reference/Pages/AMDUCA.aspx. (Accessed 20 July 2018).
9. U.S. Food and Drug Administration. 2012. CFR Title 21 Sec. 530.41, Drugs prohibited for extralabel use in animals. [WWW page]. https:// www.ecfr.gov/cgi-bin/text-idx?SID=ee1eced8027d34a9c57e1026d27f0319 &mc=true&node=se21.6.530_141&rgn=div8. (Accessed 20 July 2018).
10. Martinez-Navarro JF: Food poisoning related to consumption of illicit β-agonist in liver, Lancet 336:1311, 1990.
11. Brambilla G, Loizzo A, Fontana L, et al: Food poisoning following consumption of clenbuterol-treated veal in Italy, J Am Med Assoc 278:635, 1997.
12. Payne MA: Anti-inflammatory therapy in dairy cattle: therapeutic and regulatory considerations, California Vet 55:10, 2001.
13. Haskell SRR, Payne MA, Webb A, et al: Antidotes in food animal practice, J Am Vet Med Assoc 226:884, 2005.
14. Baynes RE, Martin-Jimenez T, Craigmill AL, et al: Estimating provisional acceptable residues for extralabel drug use in livestock, Regul Toxicol Pharmacol 29:287, 1999.
15. Martin-Jimenez T, Bayens RE, Craigmill A, et al: Extrapolated withdrawalinterval estimator (EWE) algorithm: a quantitative approach to establishing extralabel withdrawal times, Regul Toxicol Pharmacol 36:131, 2002.
16. Riviere JE, Webb AI, Craigmill AL: Primer on estimating withdrawal times after extralabel drug use, J Am Vet Med Assoc 213:966, 1998.
17. U.S. Government Printing Office. 2012. Federal Register notice announcing changes to FSIS testing methodology (Docket No. FSIS-2012-0012). [WWW page]. http://www.fsis.usda.gov/OPPDE/rdad/FRPubs/2012-0012. pdf. (Accessed July 20, 2018).